Metaglip
Metaglip is a diabetes medication containing Glipizide + Metformin, available as 2.5/500/5/500mg tablets.
Details
- Conditions
- Type 2 diabetes mellitus
- Alternative Name
- Glucovance
- Therapeutic Class
- Biguanide, Sulfonylurea
- Pharmacological Class
- Biguanide, Sulfonylurea
- Minor Side Effects
- nausea, diarrhoea, abdominal discomfort
- Moderate Side Effects
- hypoglycaemia, dizziness, weight gain
- Dosage Forms
- Tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Originator
- Bristol-Myers Squibb
- Onset Time
- 1–2 hours
- Duration
- 12–24 hours
- Storage Instructions
- Store at room temperature.
- Drug Interactions
- alcohol, cimetidine, diuretics, corticosteroids
- Age Restrictions
- Not for use in children.
What you will receive
Metaglip is the originator brand name, made by Bristol-Myers Squibb. We use it here to identify the medicine only; we are not affiliated with Bristol-Myers Squibb and do not ship the original Metaglip.
- You receive a generic equivalent: the same active ingredient (Glipizide / Metformin) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.